000 | 01986 a2200517 4500 | ||
---|---|---|---|
005 | 20250514080634.0 | ||
264 | 0 | _c20040601 | |
008 | 200406s 0 0 eng d | ||
022 | _a0007-1188 | ||
024 | 7 |
_a10.1038/sj.bjp.0705472 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHay, D L | |
245 | 0 | 0 |
_aCL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS. _h[electronic resource] |
260 |
_bBritish journal of pharmacology _cOct 2003 |
||
300 |
_a477-86 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdrenomedullin |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCOS Cells |
650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide _xpharmacology |
650 | 0 | 4 | _aCalcitonin Receptor-Like Protein |
650 | 0 | 4 | _aChlorocebus aethiops |
650 | 0 | 4 |
_aCyclic AMP _xantagonists & inhibitors |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntracellular Signaling Peptides and Proteins |
650 | 0 | 4 |
_aMembrane Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
650 | 0 | 4 |
_aPeptides _xmetabolism |
650 | 0 | 4 |
_aPiperazines _xpharmacology |
650 | 0 | 4 |
_aQuinazolines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aReceptor Activity-Modifying Protein 2 |
650 | 0 | 4 | _aReceptor Activity-Modifying Protein 3 |
650 | 0 | 4 | _aReceptor Activity-Modifying Proteins |
650 | 0 | 4 | _aReceptors, Adrenomedullin |
650 | 0 | 4 |
_aReceptors, Calcitonin _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptors, Peptide _xantagonists & inhibitors |
700 | 1 | _aHowitt, S G | |
700 | 1 | _aConner, A C | |
700 | 1 | _aSchindler, M | |
700 | 1 | _aSmith, D M | |
700 | 1 | _aPoyner, D R | |
773 | 0 |
_tBritish journal of pharmacology _gvol. 140 _gno. 3 _gp. 477-86 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0705472 _zAvailable from publisher's website |
999 |
_c12737444 _d12737444 |